Glaucoma is a leading cause of avoidable blindness worldwide. Open angle glaucoma is the most common type of glaucoma. No randomised controlled trials have been conducted evaluating the effectiveness of glaucoma screening for reducing sight loss. It is unclear what the most appropriate intervention to be evaluated in any glaucoma screening trial would be. The purpose of this study was to develop the clinical components of an intervention for evaluation in a glaucoma (open angle) screening trial that would be feasible and acceptable in a UK eye-care service.
Burr, J. M., Campbell, M. K., Campbell, S. E., Francis, J. J., Greene, A., Hernández, R., Hopkins, D., McCann, S. K., Vale, L. D., & Glaucoma screening Platform Study group (2011). Developing the clinical components of a complex intervention for a glaucoma screening trial: a mixed methods study. BMC Medical Research Methodology, 11, 54. https://doi.org/10.1186/1471-2288-11-54